OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Tianyu Cai, Agnès Gouble, Kathryn L. Black, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Tianyu Cai, Agnès Gouble, Kathryn L. Black, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Engineering immune-evasive allogeneic cellular immunotherapies
Karen E. Martin, Quirin Hammer, Karlo Perica, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 680-693
Closed Access | Times Cited: 17
Karen E. Martin, Quirin Hammer, Karlo Perica, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 680-693
Closed Access | Times Cited: 17
Cancer stem cells: Recent insights and therapies
Hongyu Zhou, Licheng Tan, Beilei Liu, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115441-115441
Closed Access | Times Cited: 32
Hongyu Zhou, Licheng Tan, Beilei Liu, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115441-115441
Closed Access | Times Cited: 32
The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia
Ben Watts, Christopher M. Smith, Kathryn L. Evans, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Ben Watts, Christopher M. Smith, Kathryn L. Evans, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, et al.
Blood Research (2023) Vol. 58, Iss. S1, pp. S90-S95
Open Access | Times Cited: 19
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, et al.
Blood Research (2023) Vol. 58, Iss. S1, pp. S90-S95
Open Access | Times Cited: 19
Ontogeny and Function of Plasmacytoid Dendritic Cells
Nicholas M. Adams, Annesa Das, Tae Jin Yun, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 347-373
Closed Access | Times Cited: 7
Nicholas M. Adams, Annesa Das, Tae Jin Yun, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 347-373
Closed Access | Times Cited: 7
Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia
Elżbieta Bartoszewska, Maciej Tota, Monika Kisielewska, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1596-1596
Open Access | Times Cited: 7
Elżbieta Bartoszewska, Maciej Tota, Monika Kisielewska, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1596-1596
Open Access | Times Cited: 7
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity
Jaquelyn T. Zoine, Kalyan Immadisetty, Jorge Ibañez-Vega, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101422-101422
Open Access | Times Cited: 6
Jaquelyn T. Zoine, Kalyan Immadisetty, Jorge Ibañez-Vega, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101422-101422
Open Access | Times Cited: 6
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123
Serena Zanotta, Domenico Galati
(2024)
Open Access | Times Cited: 5
Serena Zanotta, Domenico Galati
(2024)
Open Access | Times Cited: 5
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Hemant S. Murthy, Mei‐Jie Zhang, Karen Chen, et al.
Blood Advances (2023) Vol. 7, Iss. 22, pp. 7007-7016
Open Access | Times Cited: 12
Hemant S. Murthy, Mei‐Jie Zhang, Karen Chen, et al.
Blood Advances (2023) Vol. 7, Iss. 22, pp. 7007-7016
Open Access | Times Cited: 12
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Wei‐Ying Jen, Marina Konopleva, Naveen Pemmaraju
Cancer (2024) Vol. 130, Iss. 13, pp. 2260-2271
Closed Access | Times Cited: 4
Wei‐Ying Jen, Marina Konopleva, Naveen Pemmaraju
Cancer (2024) Vol. 130, Iss. 13, pp. 2260-2271
Closed Access | Times Cited: 4
A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council
Nasir Bakshi, Ayman Hejazi, Hatim Al-Maghraby, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 221-221
Open Access
Nasir Bakshi, Ayman Hejazi, Hatim Al-Maghraby, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 221-221
Open Access
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm
Domenico Galati, Serena Zanotta, Francesca Florio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2732-2732
Open Access
Domenico Galati, Serena Zanotta, Francesca Florio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2732-2732
Open Access
BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism
Kapil Saxena, Shao-Hsi Hung, Esther Ryu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Kapil Saxena, Shao-Hsi Hung, Esther Ryu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123
Serena Zanotta, Domenico Galati, Rosaria De Filippi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1454-1454
Open Access | Times Cited: 3
Serena Zanotta, Domenico Galati, Rosaria De Filippi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1454-1454
Open Access | Times Cited: 3
IL-3: key orchestrator of inflammation
Malgorzata J. Podolska, Robert Grützmann, Christian Pilarsky, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Malgorzata J. Podolska, Robert Grützmann, Christian Pilarsky, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development
Lorena Pérez-Amill, Álex Bataller, Julio Delgado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Lorena Pérez-Amill, Álex Bataller, Julio Delgado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review
Yemin Wang, Xiao Li, Lili Yin, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32904-e32904
Open Access | Times Cited: 7
Yemin Wang, Xiao Li, Lili Yin, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32904-e32904
Open Access | Times Cited: 7
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights
Naveen Pemmaraju, Nathaniel R. Wilson, Jayastu Senapati, et al.
Leukemia Research (2022) Vol. 121, pp. 106928-106928
Closed Access | Times Cited: 11
Naveen Pemmaraju, Nathaniel R. Wilson, Jayastu Senapati, et al.
Leukemia Research (2022) Vol. 121, pp. 106928-106928
Closed Access | Times Cited: 11
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
Yue Lü, Jianping Zhang, Yanli Zhao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 5
Yue Lü, Jianping Zhang, Yanli Zhao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 5
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells
Sarah J. Wu, Sam Sadigh, Andrew A. Lane, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 5, pp. 455-463
Closed Access | Times Cited: 5
Sarah J. Wu, Sam Sadigh, Andrew A. Lane, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 5, pp. 455-463
Closed Access | Times Cited: 5
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
Elgin Hoffmann, Simon Böke, Chiara De‐Colle, et al.
Strahlentherapie und Onkologie (2024)
Open Access | Times Cited: 1
Elgin Hoffmann, Simon Böke, Chiara De‐Colle, et al.
Strahlentherapie und Onkologie (2024)
Open Access | Times Cited: 1
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
Jasper X. Zheng, Elham Vali Betts, Denis M. Dwyre, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Jasper X. Zheng, Elham Vali Betts, Denis M. Dwyre, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells
Maxime Fredon, Margaux Poussard, Sabeha Biichlé, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 8, pp. 1090-1107
Open Access
Maxime Fredon, Margaux Poussard, Sabeha Biichlé, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 8, pp. 1090-1107
Open Access
A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients
Chen Gong, Ying Liu, Mingzhi Zhang
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access
Chen Gong, Ying Liu, Mingzhi Zhang
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access
